Fresenius Medical Care AG KGaA Total Liabilities 2010-2024 | FMS

Fresenius Medical Care AG KGaA total liabilities from 2010 to 2024. Total liabilities can be defined as the total value of all possible claims against the corporation.
  • Fresenius Medical Care AG KGaA total liabilities for the quarter ending September 30, 2024 were $19.485B, a 11.38% decline year-over-year.
  • Fresenius Medical Care AG KGaA total liabilities for 2023 were $20.675B, a 3.36% decline from 2022.
  • Fresenius Medical Care AG KGaA total liabilities for 2022 were $21.393B, a 11.31% decline from 2021.
  • Fresenius Medical Care AG KGaA total liabilities for 2021 were $24.12B, a 9.08% increase from 2020.
Fresenius Medical Care AG KGaA Annual Total Liabilities
(Millions of US $)
2023 $20,675
2022 $21,393
2021 $24,120
2020 $22,112
2019 $22,072
2018 $15,755
2017 $14,917
2016 $15,477
2015 $14,869
2014 $15,353
2013 $12,987
2012 $12,595
2011 $11,061
2010 $9,291
2009 $8,792
Fresenius Medical Care AG KGaA Quarterly Total Liabilities
(Millions of US $)
2024-09-30 $19,485
2024-06-30 $20,148
2024-03-31 $20,850
2023-12-31 $20,675
2023-09-30 $21,986
2023-06-30 $21,841
2023-03-31 $21,762
2022-12-31 $21,393
2022-09-30 $21,827
2022-06-30 $21,943
2022-03-31 $22,651
2021-12-31 $24,120
2021-09-30 $24,038
2021-06-30 $24,309
2021-03-31 $24,062
2020-12-31 $22,112
2020-09-30 $23,840
2020-06-30 $22,977
2020-03-31 $22,949
2019-12-31 $22,072
2019-09-30 $21,824
2019-06-30 $21,531
2019-03-31 $21,724
2018-12-31 $15,755
2018-09-30 $15,396
2018-06-30 $15,583
2018-03-31 $16,282
2017-12-31 $14,917
2017-09-30 $15,957
2017-06-30 $15,427
2017-03-31 $15,433
2016-12-31 $15,477
2016-09-30 $15,421
2016-06-30 $15,724
2016-03-31 $15,259
2015-12-31 $14,869
2015-09-30 $15,172
2015-06-30 $14,977
2015-03-31 $14,729
2014-12-31 $15,353
2014-09-30 $13,729
2014-06-30 $13,823
2014-03-31 $13,110
2013-12-31 $12,987
2013-09-30 $12,796
2013-06-30 $12,677
2013-03-31 $12,244
2012-12-31 $12,595
2012-09-30 $12,421
2012-06-30 $12,731
2012-03-31 $12,851
2011-12-31 $11,061
2011-09-30 $10,409
2011-06-30 $10,825
2011-03-31 $10,238
2010-12-31 $9,291
2010-09-30 $9,227
2010-06-30 $9,070
2010-03-31 $8,746
2009-12-31 $8,792
2009-09-30 $8,982
2009-06-30 $8,947
2009-03-31 $8,627
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $12.376B $21.053B
Fresenius Medical Care AG & Co. KGaA is one of the largest integrated providers of products and services for individuals undergoing dialysis. Fresenius Medical provides products and services across the entire dialysis value chain throughout the World. Fresenius Medical manufactures a variety of durable medical devices used in the treatment of End Stage Renal Disease (ESRD). Devices like Hemodialysis Machines, Peritoneal Dialysis Machines, Granuflo Concentrate Mixing Tanks and monitoring devices like the Crit-line platform are included in the company's product pipeline. The company primarily operates in - The Health Care Services segment: Consists of the company's Dialysis Services and the Care-Coordination (non-dialysis laboratory services). The Health Care Products segment: Comprises of the company's Dialysis machines, dialyzers, dialysis solutions, hemodialysis concentrates, bloodline systems, water treatment systems, dialysis drugs and other medical products..
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $214.078B 26.12
Intuitive Surgical (ISRG) United States $183.628B 96.01
Alcon (ALC) Switzerland $45.117B 31.76
IQVIA Holdings (IQV) United States $40.157B 22.12
Edwards Lifesciences (EW) United States $39.608B 24.62
IDEXX Laboratories (IDXX) United States $34.672B 40.83
DexCom (DXCM) United States $26.799B 40.36
Waters (WAT) United States $22.960B 33.95
STERIS (STE) Ireland $22.437B 25.85
SONOVA HOLDING (SONVY) Switzerland $21.922B 0.00
Hologic (HOLX) United States $18.696B 19.73
Sysmex ADR (SSMXY) Japan $11.851B 37.16
Globus Medical (GMED) United States $11.200B 28.52
Teleflex (TFX) United States $9.378B 14.96
Penumbra (PEN) United States $8.969B 87.86
Masimo (MASI) United States $8.917B 43.43
Glaukos (GKOS) United States $7.755B 0.00
PROCEPT BioRobotics (PRCT) United States $5.126B 0.00
Integer Holdings (ITGR) United States $4.542B 25.75
Inari Medical (NARI) United States $3.119B 0.00
TransMedics (TMDX) United States $2.898B 91.86
LivaNova (LIVN) United Kingdom $2.829B 16.33
Veracyte (VCYT) United States $2.811B 85.09
Nihon Kohden (NHNKY) Japan $2.519B 15.68
Tandem Diabetes Care (TNDM) United States $2.242B 0.00
Elekta AB (EKTAY) Sweden $2.227B 18.14
Integra LifeSciences Holdings (IART) United States $2.060B 10.77
RxSight (RXST) United States $2.024B 0.00
Alphatec Holdings (ATEC) United States $1.257B 0.00
Artivion (AORT) United States $1.233B 113.23
Pulse Biosciences (PLSE) United States $1.110B 0.00
OPKO Health (OPK) United States $1.025B 0.00
AVANOS MEDICAL, INC (AVNS) United States $0.963B 16.37
OrthoPediatrics (KIDS) United States $0.749B 0.00
Mesa Laboratories (MLAB) United States $0.726B 18.33
Pacific Biosciences Of California (PACB) United States $0.722B 0.00
IRadimed (IRMD) United States $0.712B 38.49
ORTHOFIX MEDICAL INC (OFIX) United States $0.702B 0.00
AxoGen (AXGN) United States $0.672B 0.00
SiBone (SIBN) United States $0.669B 0.00
Paragon 28 (FNA) United States $0.605B 0.00
Treace Medical Concepts (TMCI) United States $0.485B 0.00
CVRx (CVRX) United States $0.374B 0.00
ClearPoint Neuro (CLPT) United States $0.369B 0.00
Tactile Systems Technology (TCMD) United States $0.351B 18.99
Delcath Systems (DCTH) United States $0.304B 0.00
AngioDynamics (ANGO) United States $0.301B 0.00
Semler Scientific (SMLR) United States $0.291B 19.57
Sight Sciences (SGHT) United States $0.257B 0.00
NeuroPace (NPCE) United States $0.228B 0.00
Inogen (INGN) United States $0.227B 0.00
Nevro (NVRO) United States $0.216B 0.00
Accuray (ARAY) United States $0.204B 0.00
Atossa Genetics (ATOS) United States $0.186B 0.00
Alpha Tau Medical (DRTS) Israel $0.160B 0.00
908 Devices (MASS) United States $0.136B 0.00
KORU Medical Systems (KRMD) United States $0.129B 0.00
Spectral Diagnostics (EDTXF) Canada $0.116B 0.00
Sensus Healthcare (SRTS) United States $0.110B 16.32
EDAP TMS S.A (EDAP) France $0.105B 0.00
WORK Medical Technology Group (WOK) China $0.087B 0.00
Monogram Orthopaedics (MGRM) United States $0.077B 0.00
Hyperfine (HYPR) United States $0.070B 0.00
LENSAR (LNSR) United States $0.068B 0.00
Covalon Technologies (CVALF) Canada $0.068B 0.00
InspireMD (NSPR) Israel $0.061B 0.00
EnVVeno Medical (NVNO) United States $0.060B 0.00
Lucid Diagnostics (LUCD) United States $0.051B 0.00
Rapid Micro Biosystems (RPID) United States $0.049B 0.00
Accelerate Diagnostics (AXDX) United States $0.047B 0.00
Vicarious Surgical (RBOT) United States $0.046B 0.00
Envoy Medical (COCH) United States $0.038B 0.00
Neuronetics (STIM) United States $0.036B 0.00
Adagio Medical Holdings (ADGM) United States $0.036B 0.00
DarioHealth (DRIO) United States $0.030B 0.00
Precision Optics (POCI) United States $0.029B 0.00
Spectral AI (MDAI) United States $0.028B 0.00
Biosig Technologies (BSGM) United States $0.028B 0.00
Ekso Bionics Holdings (EKSO) United States $0.020B 0.00
Baird Medical Investment Holdings (BDMD) $0.019B 0.00
NexGel (NXGL) United States $0.018B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.016B 0.00
Microbot Medical (MBOT) United States $0.016B 0.00
Autonomix Medical (AMIX) United States $0.015B 0.00
Aspira Women's Health (AWH) United States $0.014B 0.00
QT Imaging Holdings (QTI) United States $0.012B 0.00
Pixie Dust Technologies (PXDT) Japan $0.012B 0.00
T2 Biosystems (TTOO) United States $0.012B 0.00
PAVmed (PAVM) United States $0.011B 0.00
Check-Cap (CHEK) Israel $0.007B 0.00
ENDRA Life Sciences (NDRA) United States $0.004B 0.00
Nuwellis (NUWE) United States $0.003B 0.00
Venus Concept (VERO) Canada $0.003B 0.00
ReShape Lifesciences (RSLS) United States $0.003B 0.00
Helius Medical Technologies (HSDT) United States $0.002B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.002B 0.00
Avinger (AVGR) United States $0.002B 0.00
Nanovibronix (NAOV) United States $0.002B 0.00
Tenon Medical (TNON) United States $0.002B 0.00
Bluejay Diagnostics (BJDX) United States $0.002B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00